Limits...
Survey of familial glaucoma shows a high incidence of cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in non-consanguineous congenital forms in a Spanish population.

Mill√° E, Ma√Ī√© B, Duch S, Hernan I, Borr√†s E, Planas E, Dias Mde S, Carballo M, Gamundi MJ, Spanish Multicenter Glaucoma Group-Estudio Multic√©ntrico Espa√Īol de Investigaci√≥n Gen√©tica del Glaucoma, EMEI - Mol. Vis. (2013)

Bottom Line: One hundred two of the families (including all those in whom a MYOC mutation was detected) were also screened for CYP1B1 mutations: 45 POAG, 25 PCG, 21 JOAG, four ARS, and seven others.CYP1B1 mutations were found in 16 index patients with PCG (nine), POAG (three), JOAG (two), and ARS (two).The high percentage (9/25=36%) of mutations in CYP1B1 found in non-consanguineous patients with congenital glaucoma mandates genetic testing.

View Article: PubMed Central - PubMed

Affiliation: Unidad de Glaucoma y Genética, Institut Comtal d'Oftalmologia, Barcelona, Spain.

ABSTRACT

Purpose: To identify myocilin (MYOC) and cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in a Spanish population with different clinical forms of familial glaucoma or ocular hypertension (OHT).

Methods: Index patients from 226 families participated in this study. Patients were diagnosed with familial glaucoma or OHT by complete ophthalmologic examination. Screening for MYOC mutations was performed in 207 index patients: 96 with adult-onset primary open-angle glaucoma (POAG), 21 with primary congenital glaucoma (PCG), 18 with juvenile-onset open-angle glaucoma (JOAG), five with Axenfeld-Rieger syndrome (ARS), and 67 with other types of glaucoma. One hundred two of the families (including all those in whom a MYOC mutation was detected) were also screened for CYP1B1 mutations: 45 POAG, 25 PCG, 21 JOAG, four ARS, and seven others.

Results: We examined 292 individuals (patients and relatives) with a positive family history of glaucoma or OHT. We identified two novel MYOC variants, p.Lys39Arg and p.Glu218Lys, in two families with POAG, and six previously reported MYOC mutations in seven families with POAG (four), JOAG (one), PCG (one), and normotensive glaucoma (one). CYP1B1 mutations were found in 16 index patients with PCG (nine), POAG (three), JOAG (two), and ARS (two).

Conclusions: The high percentage (9/25=36%) of mutations in CYP1B1 found in non-consanguineous patients with congenital glaucoma mandates genetic testing. However, the percentage of mutations (9/207=4.4%) in MYOC associated with glaucoma is relatively low in our population. The variable phenotype expression of glaucoma, even in families, cannot be explained with a digenic mechanism between MYOC and CYP1B1.

Show MeSH

Related in: MedlinePlus

Pedigrees of glaucoma families from the Estudio Multic√©ntrico Espa√Īol de Investigaci√≥n Gen√©tica del Glaucoma (EMEIGG) carrying mutations in CYP1B1. Filled symbols represent affected subjects, and unfilled symbols unaffected subjects. Squares indicate men, and circles women. Arrows represent the index patients. WT depicts the wild-type allele.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3733905&req=5

f3: Pedigrees of glaucoma families from the Estudio Multic√©ntrico Espa√Īol de Investigaci√≥n Gen√©tica del Glaucoma (EMEIGG) carrying mutations in CYP1B1. Filled symbols represent affected subjects, and unfilled symbols unaffected subjects. Squares indicate men, and circles women. Arrows represent the index patients. WT depicts the wild-type allele.

Mentions: The mutation p.Gly61Glu was detected in compound heterozygosis [36] with p.Leu277Stop in patient II:2 of family EMEIGG-12005 (Figure 3) who showed a severe phenotype. Individuals of this family carrying one of these two mutations were unaffected.


Survey of familial glaucoma shows a high incidence of cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in non-consanguineous congenital forms in a Spanish population.

Mill√° E, Ma√Ī√© B, Duch S, Hernan I, Borr√†s E, Planas E, Dias Mde S, Carballo M, Gamundi MJ, Spanish Multicenter Glaucoma Group-Estudio Multic√©ntrico Espa√Īol de Investigaci√≥n Gen√©tica del Glaucoma, EMEI - Mol. Vis. (2013)

Pedigrees of glaucoma families from the Estudio Multic√©ntrico Espa√Īol de Investigaci√≥n Gen√©tica del Glaucoma (EMEIGG) carrying mutations in CYP1B1. Filled symbols represent affected subjects, and unfilled symbols unaffected subjects. Squares indicate men, and circles women. Arrows represent the index patients. WT depicts the wild-type allele.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3733905&req=5

f3: Pedigrees of glaucoma families from the Estudio Multic√©ntrico Espa√Īol de Investigaci√≥n Gen√©tica del Glaucoma (EMEIGG) carrying mutations in CYP1B1. Filled symbols represent affected subjects, and unfilled symbols unaffected subjects. Squares indicate men, and circles women. Arrows represent the index patients. WT depicts the wild-type allele.
Mentions: The mutation p.Gly61Glu was detected in compound heterozygosis [36] with p.Leu277Stop in patient II:2 of family EMEIGG-12005 (Figure 3) who showed a severe phenotype. Individuals of this family carrying one of these two mutations were unaffected.

Bottom Line: One hundred two of the families (including all those in whom a MYOC mutation was detected) were also screened for CYP1B1 mutations: 45 POAG, 25 PCG, 21 JOAG, four ARS, and seven others.CYP1B1 mutations were found in 16 index patients with PCG (nine), POAG (three), JOAG (two), and ARS (two).The high percentage (9/25=36%) of mutations in CYP1B1 found in non-consanguineous patients with congenital glaucoma mandates genetic testing.

View Article: PubMed Central - PubMed

Affiliation: Unidad de Glaucoma y Genética, Institut Comtal d'Oftalmologia, Barcelona, Spain.

ABSTRACT

Purpose: To identify myocilin (MYOC) and cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in a Spanish population with different clinical forms of familial glaucoma or ocular hypertension (OHT).

Methods: Index patients from 226 families participated in this study. Patients were diagnosed with familial glaucoma or OHT by complete ophthalmologic examination. Screening for MYOC mutations was performed in 207 index patients: 96 with adult-onset primary open-angle glaucoma (POAG), 21 with primary congenital glaucoma (PCG), 18 with juvenile-onset open-angle glaucoma (JOAG), five with Axenfeld-Rieger syndrome (ARS), and 67 with other types of glaucoma. One hundred two of the families (including all those in whom a MYOC mutation was detected) were also screened for CYP1B1 mutations: 45 POAG, 25 PCG, 21 JOAG, four ARS, and seven others.

Results: We examined 292 individuals (patients and relatives) with a positive family history of glaucoma or OHT. We identified two novel MYOC variants, p.Lys39Arg and p.Glu218Lys, in two families with POAG, and six previously reported MYOC mutations in seven families with POAG (four), JOAG (one), PCG (one), and normotensive glaucoma (one). CYP1B1 mutations were found in 16 index patients with PCG (nine), POAG (three), JOAG (two), and ARS (two).

Conclusions: The high percentage (9/25=36%) of mutations in CYP1B1 found in non-consanguineous patients with congenital glaucoma mandates genetic testing. However, the percentage of mutations (9/207=4.4%) in MYOC associated with glaucoma is relatively low in our population. The variable phenotype expression of glaucoma, even in families, cannot be explained with a digenic mechanism between MYOC and CYP1B1.

Show MeSH
Related in: MedlinePlus